Emerging Therapies for Overlapping Diseases

This chapter explores the burden of risk factors such as obesity, diabetes, kidney disease, and heart disease and highlights new therapies like SGLT2 inhibitors and GLP1 receptor agonists that have emerged with cardiovascular benefits and benefits for people with diabetes, kidney disease, and obesity.